Parallax Volatility Advisers’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-53,243
Closed -$200K 2815
2018
Q2
$200K Buy
+53,243
New +$200K ﹤0.01% 420
2018
Q1
Sell
-13,608
Closed -$63K 3874
2017
Q4
$63K Buy
+13,608
New +$63K ﹤0.01% 1972
2016
Q1
Sell
-32,066
Closed -$162K 2260
2015
Q4
$162K Buy
+32,066
New +$162K ﹤0.01% 492
2015
Q3
Sell
-47,962
Closed -$479K 2476
2015
Q2
$479K Buy
+47,962
New +$479K ﹤0.01% 439